Cecropia peltata (Urticaceae) Trumpet Tree, Yagrumo Hembra, Guarumo, Gummy Worm Fruit
Cecropia peltata is the sister species to C. obtusifolia in Mexican traditional medicine, used interchangeably by the diabetic population as a cold infusion consumed throughout the day . Preclinical evidence suggests it may actually be the more potent hypoglycemic agent of the two: in a direct comparison, C. peltata (containing 19.84 mg chlorogenic acid/g dried leaf) produced a 52.8% reduction in plasma glucose in healthy mice, with a linear dose-response relationship and an ED50 of 0.540 g/kg for the extract . Mechanistically, its aqueous extract inhibited glucose-6-phosphatase with an IC50 of 146 μg/mL—more potent than C. obtusifolia (224 μg/mL) in the same assay . The fruit, known informally as the "Gummy Worm Fruit" for its soft, viscous, jelly-like flesh, is also edible and consumed locally . Despite this promising preclinical profile, no human clinical trial specific to C. peltata was found in the search results; the human trial evidence belongs to C. obtusifolia. Safety data are reassuring, with no genotoxic or clastogenic effects observed in multiple assays . The species is also a documented invasive alien in several tropical regions .
---
1. Taxonomic Insights
Species: Cecropia peltata L.
Family: Urticaceae (Nettle Family; formerly Cecropiaceae)
Genus: Cecropia
Synonyms: Cecropia schiedeana Klotzsch
---
Botanical Description
Cecropia peltata is a dioecious tree reaching 15 to 25 metres in height, with hollow internodes and a characteristic umbrella-like crown .
Key Identification Features:
Leaves are peltate (petiole attached to the center of the blade), with 8 to 10 lobes, each lobe 10 to 60 centimetres long, distally free, oblong or elliptic, with shortly acuminate to rounded apices. The petiole is 20 to 50 centimetres long, with trichilia (fused hairs) at the base. Stipules are 3 to 12 centimetres long, pinkish or reddish. Male inflorescences are erect to deflexed with peduncles 2 to 12.5 centimetres long; female inflorescences are in pairs, with spikes 3 to 4 (up to 5), 1 to 4 centimetres long. Fruits are ovoid to ellipsoid, about 2 millimetres long, tuberculate, dark brown .
Distribution: Native from southern Mexico to northern South America, also in Jamaica and Trinidad. Introduced and invasive in Africa, Singapore, Malaysia, Indonesia, and parts of Australia (North Coast NSW and Queensland) .
Conservation Status: Not assessed as threatened in its native range. Listed in the Global Invasive Species Database as a species capable of forming dense stands that compete with and displace native pioneer species .
---
Etymology
The generic name Cecropia is derived from Cecrops, the mythical first king of Athens. The specific epithet peltata is Latin for "shield-bearing," referring to the peltate leaf attachment. The informal name "Gummy Worm Fruit" derives from the soft, viscous, jelly-like texture of the ripe fruit flesh, which is often compared to the chewy consistency of gummy worm candy .
---
2. Common Names
Scientific Name: Cecropia peltata | English: Trumpet Tree, Snake Finger, Yagrumo Hembra, Gummy Worm Fruit | Spanish: Yagrumo Hembra, Guarumo, Loro | Portuguese: Embaúba | French: Bois Cannon
---
3. Related Herbs from the Urticaceae Family
Cecropia obtusifolia (Guarumo Blanco): The closest relative and the species with human clinical trial evidence for diabetes. It shares the same active constituents (chlorogenic acid, isoorientin) but appears less potent in preclinical assays .
Urtica dioica (Stinging Nettle): The most famous medicinal Urticaceae, with well-documented anti-inflammatory and diuretic properties. It shares the family's tendency toward phenolic-rich leaves.
The Urticaceae family is characterized by the presence of phenolic acids (particularly chlorogenic acid) and flavonoids.
---
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions (Preclinical):
Antidiabetic / Hypoglycemic (Leaves): C. peltata methanol extract produced a 52.8% reduction in plasma glucose in healthy mice at 1 g/kg, with a linear dose-response relationship (ED50 0.540 g/kg for extract; ED50 10.8 mg/kg for chlorogenic acid). The effect correlated with chlorogenic acid content, and the authors concluded C. peltata is a "better hypoglycemic agent than C. obtusifolia" and could be considered for developing a phytomedicinal product for clinical trials . Mechanistically, the aqueous extract inhibited glucose-6-phosphatase with an IC50 of 146 μg/mL, reducing hepatic glucose output .
Secondary Actions (Documented in Secondary Sources):
· Cardiovascular, Respiratory, Sedative, Antimicrobial, Kidney Infections, Wound Healing: A table of traditional uses for Cecropia species lists these applications for C. peltata, though without primary documentation in the search results .
---
Medicinal Parts
Leaves: The primary medicinal part, used as a cold infusion ("agua de uso") in Mexican traditional medicine for diabetes . Source of chlorogenic acid and isoorientin.
Fruit: Edible and consumed locally. Known informally as the "Gummy Worm Fruit" due to its soft, viscous, jelly-like flesh, which is described as having a texture reminiscent of gummy worm candy . The fruit is not a primary medicinal part in the literature but is a documented food use.
---
5. Phytochemistry
5.1 Phenolic Acids and Flavonoids (Leaves)
The main constituents confirmed by HPLC-DAD are chlorogenic acid and isoorientin . A 2023 metabolomic study of C. peltata from Tabasco, Mexico, quantified chlorogenic acid (up to 39.8 mg/g in one sub-region), isoorientin (up to 51.5 mg/g), orientin (up to 49.9 mg/g), and a vitexin analog (6.2 mg/g), demonstrating intraspecies variation across collection sites .
5.2 Chlorogenic Acid Content
C. peltata leaves contained 19.84 ± 1.64 mg chlorogenic acid/g dried leaf in the 2005 study . The 2023 study found higher concentrations (up to 39.8 mg/g) in specific sub-regions of Tabasco .
5.3 Other Compounds
Triterpenes, sterols, steroids, ursolic acid, and a D-glucan (glycogen-type polysaccharide) have been identified in C. peltata .
---
6. Mechanisms of Action
6.1 Antidiabetic Activity
The hypoglycemic effect is attributed to inhibition of glucose-6-phosphatase, the enzyme that catalyzes the final step of gluconeogenesis. By inhibiting this enzyme, C. peltata reduces hepatic glucose output, particularly in the fasting state. The aqueous extract inhibited the enzyme with an IC50 of 146 μg/mL . Chlorogenic acid is the primary active constituent responsible for this effect, acting as a glucose-6-phosphate translocase inhibitor .
6.2 Safety Profile
The hydroalcoholic extract showed no clastogenic activity in ex vivo plasmid DNA assays at concentrations up to 1000 μg/mL for 30 minutes . A rodent micronucleus assay also found no genotoxic effects . These results support the safety of C. peltata for further preclinical studies .
---
7. Traditional and Ethnobotanical Uses
7.1 Diabetes (Leaves, Mexican Traditional Medicine)
Formulation: Cold infusion ("agua de uso") consumed over the course of a day .
Preparation and Use: The plant is used by the Mexican diabetic population to treat type 2 diabetes, particularly in Mayan communities of south-eastern Mexico .
Scientific Validation: Preclinical studies demonstrate hypoglycemic activity and glucose-6-phosphatase inhibition . No human clinical trial specific to C. peltata was found in the search results.
7.2 Other Traditional Uses (Unverified)
A table of traditional uses for Cecropia species lists C. peltata for cardiovascular, metabolic, and respiratory conditions, as a sedative, antimicrobial, for kidney infections, and wound healing . No primary documentation for these specific uses was found in the search results.
7.3 Food (Fruit)
The fruit is edible and consumed locally. It is known informally as the "Gummy Worm Fruit" for its soft, viscous, jelly-like flesh, which is likened to the texture of gummy worm candy .
---
8. Healing Recipes, Teas, Decoctions, and Culinary Uses
8.1 Traditional Cold Infusion ("Agua de Uso") for Diabetes
Purpose: Traditional preparation for managing blood sugar.
Preparation and Use: A cold infusion of the leaves is prepared and consumed over the course of a day, as documented in Mexican traditional medicine .
Scientific Validation: Supported by preclinical data demonstrating hypoglycemic activity and glucose-6-phosphatase inhibition . Human clinical validation is lacking for this specific species.
8.2 Fresh Gummy Worm Fruit
Purpose: A local food source with a unique texture.
Preparation and Use: The ripe fruit is consumed fresh. Its soft, viscous, jelly-like flesh has earned it the informal name "Gummy Worm Fruit" .
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Antidiabetic (Leaves): Moderate evidence from preclinical studies. C. peltata produced a 52.8% reduction in plasma glucose in healthy mice, with a linear dose-response and ED50 of 0.540 g/kg. The effect correlated with chlorogenic acid content . The aqueous extract inhibited glucose-6-phosphatase with an IC50 of 146 μg/mL . No human clinical trial specific to C. peltata exists.
Genotoxicity Safety: Moderate evidence from multiple assays. No clastogenic effects in ex vivo plasmid DNA assays at up to 1000 μg/mL . No genotoxic effects in rodent micronucleus assay .
Critical Gap: The human clinical evidence for diabetes belongs to C. obtusifolia, not C. peltata. While the two species are used interchangeably by the Mexican population , the clinical trial was conducted only on C. obtusifolia. Independent clinical validation of C. peltata is needed.
---
10. Safety and Toxicology
10.1 Toxicity Profile
Leaves (Hydroalcoholic Extract): No clastogenic activity in ex vivo plasmid DNA assays at 1, 10, 100, and 1000 μg/mL for 30 minutes, and no breaks up to 4 hours at the highest non-clastogenic concentration . No genotoxic effects in rodent micronucleus assay .
Fruit: Consumed as food. No toxicity data were found in the search results.
General: Toxicological studies on Cecropia species are limited, with most focusing on C. obtusifolia. More comprehensive toxicological evaluations of the genus are needed .
10.2 Contraindications and Precautions
Pregnancy and Lactation: No safety data exist. Consult a healthcare provider.
Diabetes Medications: The plant has demonstrated significant hypoglycemic activity in animals. Additive effects with insulin or oral hypoglycemics are theoretically possible, and blood glucose should be monitored if combined.
10.3 Potential Drug Interactions
No formal drug interaction studies were found. Based on the demonstrated hypoglycemic mechanism , there is a theoretical potential for additive blood sugar lowering with antidiabetic medications.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
For Leaves: Chlorogenic acid and isoorientin are the main constituents confirmed by HPLC-DAD and are associated with the hypoglycemic activity . Chlorogenic acid content is directly correlated with hypoglycemic potency .
11.2 Recommended Analytical Methods
HPLC-DAD for quantification of chlorogenic acid and isoorientin, as used in the mechanistic studies . The 2023 study also used 1H-NMR fingerprinting for metabolomic profiling .
11.3 Suggested Specifications
No official pharmacopoeial specifications exist. For research-grade leaf extracts, specifications would include minimum chlorogenic acid content (targeting the higher concentrations found in specific Mexican sub-regions) and verified glucose-6-phosphatase inhibitory activity .
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Tropical, with mean annual temperatures of 12 to 24°C. Requires high rainfall (990 to over 3810 mm annually) .
Habitat: A fast-growing, high-light-demanding pioneer species that colonizes forest gaps and disturbed sites. Grows in alluvial, colluvial, and residual soils, from heavy clay to sandy, with clay-loam optimal .
Propagation: Dioecious, becoming sexually mature in 3 to 5 years. Wind-pollinated. Each female spike produces around 800 viable seeds, dispersed by bats and birds. Forms a large and persistent seedbank .
12.2 Sustainable Harvesting
Leaves are the primary harvest for medicinal use. The species is fast-growing and common, suggesting sustainable harvest is feasible. The fruit is also harvested locally for food.
12.3 Conservation Status
Not assessed as threatened in its native range. However, it is listed as an invasive species in Africa, Singapore, Malaysia, Indonesia, and parts of Australia, where it forms dense stands that compete with and displace native pioneer species .
---
13. Research Gaps and Future Directions
13.1 Critical Research Gaps
Human Clinical Trials: No human clinical trial specific to C. peltata was found. The clinical evidence belongs to C. obtusifolia . Given the preclinical data suggesting C. peltata may be more potent , a clinical trial of this species is warranted.
Active Compound Contributions: While chlorogenic acid is established as a key active constituent, the contributions of isoorientin and other compounds require further study.
Long-Term Safety: No chronic toxicity studies were found.
Fruit Research: The fruit, despite its local food use and unique texture, has not been characterized for nutritional composition or bioactivity.
13.2 Future Research Priorities
Randomized Controlled Trial: A double-blind, placebo-controlled trial of a standardized C. peltata leaf extract in type 2 diabetic patients, building on the preclinical data showing superiority to C. obtusifolia .
Standardized Extract Development: Development of an extract with defined chlorogenic acid content, given the correlation between chlorogenic acid and hypoglycemic potency .
Fruit Valorization: Nutritional and sensory analysis of the "Gummy Worm Fruit," given its local food use .
---
14. Commercial Applications
14.1 Pharmaceutical and Nutraceutical Potential
Antidiabetic Phytopharmaceutical (Promising): The combination of preclinical efficacy, mechanistic data, and safety profile positions C. peltata as a candidate for development, particularly given the authors' conclusion that it is a "better hypoglycemic agent than C. obtusifolia" and should be considered for clinical trials .
14.2 Application-Specific Product Development
Standardized Leaf Extract: Capsules or powders standardized to chlorogenic acid for blood sugar support, pending clinical validation.
Specialty Fruit Product (Potential): The "Gummy Worm Fruit" could be developed as a niche food product, leveraging its unique texture and local appeal.
---
15. Related Plants for Further Study
Cecropia obtusifolia: The species with human clinical trial evidence. Comparative clinical studies would clarify whether the preclinical superiority of C. peltata translates to humans.
---
16. Reference Literature
Primary Research
· Nicasio, P., et al. (2005). "Hypoglycemic effect and chlorogenic acid content in two Cecropia species." Phytotherapy Research 19(8): 661-664. Key comparative study demonstrating C. peltata as the more potent hypoglycemic agent .
· Andrade-Cetto, A., et al. (2010). "Gluconeogenesis inhibition and phytochemical composition of two Cecropia species." Journal of Ethnopharmacology 130(1): 93-97. Mechanistic study on glucose-6-phosphatase inhibition .
· (2023). "Metabolic analysis and 1H-NMR fingerprinting of Cecropia peltata and Cecropia obtusifolia from Tabasco, Mexico." Google Scholar. Quantification of chlorogenic acid, isoorientin, orientin, and vitexin analog across sub-regions .
· (2025). Genotoxicity evaluation of C. peltata hydroalcoholic extract using ex vivo plasmid DNA and rodent micronucleus assays .
Key Monographs and Floras
· PlantNET NSW: Detailed botanical description, distribution, and invasive status .
· Global Invasive Species Database: Ecology, reproduction, and management information .
· OAS Medicinal Plants of Panama: Phytochemical constituents (triterpenes, ursolic acid, D-glucan) .
· Specialty Produce: Informal "Gummy Worm Fruit" name and fruit description .
---
17. Disclaimer
The leaves of Cecropia peltata have been used traditionally for diabetes and have demonstrated significant hypoglycemic effects in preclinical studies. The fruit is consumed locally as a food.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
No human clinical trial specific to C. peltata was found. The clinical evidence for diabetes belongs to the related species C. obtusifolia. Preclinical data suggest C. peltata may be more potent, but this has not been confirmed in humans.
Individuals with diabetes should not replace prescribed medications with this plant without consulting a healthcare provider. Blood glucose should be monitored closely if combining with antidiabetic medications due to the potential for additive effects.
Proper identification is crucial. Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments